Clinical trial
An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis
NCT04077567 is registered in ClinicalTrials.gov with Taisho Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis
- Lead sponsor
- Taisho Pharmaceutical Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 1, 2019
- Completion date
- April 28, 2023
- Enrollment
- 401 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis